55 related articles for article (PubMed ID: 19041759)
1. A two-step pathway to resist fasting.
Kaestner KH
Cell Metab; 2008 Dec; 8(6):449-51. PubMed ID: 19041759
[TBL] [Abstract][Full Text] [Related]
2. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.
Liu Y; Dentin R; Chen D; Hedrick S; Ravnskjaer K; Schenk S; Milne J; Meyers DJ; Cole P; Yates J; Olefsky J; Guarente L; Montminy M
Nature; 2008 Nov; 456(7219):269-73. PubMed ID: 18849969
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.
Zhang P; Tu B; Wang H; Cao Z; Tang M; Zhang C; Gu B; Li Z; Wang L; Yang Y; Zhao Y; Wang H; Luo J; Deng CX; Gao B; Roeder RG; Zhu WG
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10684-9. PubMed ID: 25009184
[TBL] [Abstract][Full Text] [Related]
4. PCAF represses transactivation function of FOXO1 in an acetyltransferase-independent manner.
Yoshimochi K; Daitoku H; Fukamizu A
J Recept Signal Transduct Res; 2010 Feb; 30(1):43-9. PubMed ID: 20041807
[TBL] [Abstract][Full Text] [Related]
5. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway.
Mortuza R; Chen S; Feng B; Sen S; Chakrabarti S
PLoS One; 2013; 8(1):e54514. PubMed ID: 23342163
[TBL] [Abstract][Full Text] [Related]
6. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes.
Frescas D; Valenti L; Accili D
J Biol Chem; 2005 May; 280(21):20589-95. PubMed ID: 15788402
[TBL] [Abstract][Full Text] [Related]
7. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
Puigserver P; Rhee J; Donovan J; Walkey CJ; Yoon JC; Oriente F; Kitamura Y; Altomonte J; Dong H; Accili D; Spiegelman BM
Nature; 2003 May; 423(6939):550-5. PubMed ID: 12754525
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
9. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity.
Nakae J; Cao Y; Daitoku H; Fukamizu A; Ogawa W; Yano Y; Hayashi Y
J Clin Invest; 2006 Sep; 116(9):2473-83. PubMed ID: 16917544
[TBL] [Abstract][Full Text] [Related]
10. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
Yang Y; Hou H; Haller EM; Nicosia SV; Bai W
EMBO J; 2005 Mar; 24(5):1021-32. PubMed ID: 15692560
[TBL] [Abstract][Full Text] [Related]
11. Reply to Leithner et al.: Focus on phopshoenolpyruvate carboxykinase (PEPCK): a target of the p53-SIRT6-FoxO1 axis.
Li Z; Zhu WG
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4395. PubMed ID: 25261554
[No Abstract] [Full Text] [Related]
12. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
[TBL] [Abstract][Full Text] [Related]
13. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction.
Al-Regaiey KA; Masternak MM; Bonkowski M; Sun L; Bartke A
Endocrinology; 2005 Feb; 146(2):851-60. PubMed ID: 15498882
[TBL] [Abstract][Full Text] [Related]
14. Gluconeogenesis in cancer: door wide open.
Leithner K; Hrzenjak A; Olschewski H
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4394. PubMed ID: 25261555
[No Abstract] [Full Text] [Related]
15. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes.
Kodama S; Koike C; Negishi M; Yamamoto Y
Mol Cell Biol; 2004 Sep; 24(18):7931-40. PubMed ID: 15340055
[TBL] [Abstract][Full Text] [Related]
16. [Nuclear FoxO1 as a bridge between metabolism and mitogenesis].
Naïmi M; Van Obberghen E
Med Sci (Paris); 2008; 24(6-7):635-9. PubMed ID: 18601882
[TBL] [Abstract][Full Text] [Related]
17. The role of transcriptional regulators in central control of appetite and body weight.
Coppari R; Ramadori G; Elmquist JK
Nat Clin Pract Endocrinol Metab; 2009 Mar; 5(3):160-6. PubMed ID: 19229236
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment.
Borradaile NM; Pickering JG
Aging Cell; 2009 Apr; 8(2):100-12. PubMed ID: 19302375
[TBL] [Abstract][Full Text] [Related]
19. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway.
Nemoto S; Fergusson MM; Finkel T
Science; 2004 Dec; 306(5704):2105-8. PubMed ID: 15604409
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway.
Wang GL; Fu YC; Xu WC; Feng YQ; Fang SR; Zhou XH
Biochem Biophys Res Commun; 2009 Mar; 380(3):644-9. PubMed ID: 19285015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
